Media and related solutions for protein-based therapies.

To maximize the performance of CHO cells, it is necessary to select the optimal medium for each clone and further optimize the process parameters. Sartorius offers a variety of basic media and feeds suitable for Fed-batch culture of major CHO cell lines such as CHO-DG44, K1, S, and GS. In this webinar, we will introduce a case study that combines these CHO media, the automated microbioreactor Ambr15, and the experimental design software MODDE to conduct medium screening and process optimization in a short period. We will also provide information about our Benchmark Study service, which allows you to outsource the selection of the optimal medium and process development for your specific cell line to our research institute in Germany. 【Seminar Overview】 ▪ Date: March 6, 2025 (Thursday) from 3:00 PM (approximately 40 minutes) ▪ Method: Webinar recorded broadcast [Japanese, Free] If you are unable to participate on the day, please register first. We will send you a viewing URL later. *We kindly ask that participants from other companies in the same industry, as well as those using email addresses not affiliated with your organization, refrain from joining. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The media required for pharmaceutical development varies by development phase, making it important to choose a media partner with flexible options and a robust supply system. This webinar will focus on CHO media, introducing services for developing media with optimal compositions for your cell lines, prototype manufacturing services for supplying specified compositions in a short period, and a global manufacturing system that supports commercial production. 【Seminar Overview】 ▪ Date: September 5 (Thursday) from 15:00 (approximately 30 minutes) ▪ Method: Webinar recorded broadcast [Japanese, free] If you are unable to participate on the day, please register first. We will send you the URL for viewing later. *We regret to inform you that participation from other companies in the same industry and email addresses not associated with your organization is not permitted. Thank you for your understanding.